The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b - PubMed (original) (raw)
The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b
T Fujita et al. J Exp Med. 1979.
Abstract
Two forms of C4-binding protein (C4-bp) (C4-bp low, C4-bp high), which differ slightly in net charge and apparent molecular weight, as determined by SDS- PAGE, were separated by ion-exchange chromatography and contaminants removed with specific antisera. Both forms of C4-bp served as cofactors for the cleavage of C4b in solution by C3b inactivator, and the resulting fragments of the a'-chain of C4b had identical molecular weights. In addition, similarly to beta1H, C4-bp low or high served as cofactors for the cleavage of fluid phase C3b by C3bINA. However, important quantitative differences between the activities of C4-bp and beta1H were observed. With regard to C3b in solution, the cofactor activity of beta1H was {approximately equal to}20 times greater than that of C4-bp on a weight basis. In relation to cell-bound C3b, the differences in activity were even more marked. Whereas beta1H enhanced the effects of C3bINA on the erythrocyte intermediate EC3b, inhibiting the assembly of EC3bBb, C4-bp was without effect even at concentrations {approximately equal to}300 times greater than beta1H. Therefore, under physiological conditions, it is likely that beta1H is the key protein which controls the function of C3b, and that C4-bp activity is directed mainly toward the cleavage of C4b. We also examined the relation between C4-bp and the C3b-C4bINA cofactor described by Stroud and collaborators (3, 4). By functional, physico-chemical and immunological criteria, they are the same protein.
Similar articles
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Pangburn MK, et al. J Exp Med. 1977 Jul 1;146(1):257-70. doi: 10.1084/jem.146.1.257. J Exp Med. 1977. PMID: 301546 Free PMC article. - Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
Fujita T, Gigli I, Nussenzweig V. Fujita T, et al. J Exp Med. 1978 Oct 1;148(4):1044-51. doi: 10.1084/jem.148.4.1044. J Exp Med. 1978. PMID: 702059 Free PMC article. - Mouse C3b/C4b inactivator: purification and properties.
Kai S, Fujita T, Gigli I, Nussenzweig V. Kai S, et al. J Immunol. 1980 Dec;125(6):2409-15. J Immunol. 1980. PMID: 6776193 - Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF. Fearon DT, et al. Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review. - C3b inactivator and beta 1H.
Crossley LG. Crossley LG. Methods Enzymol. 1981;80 Pt C:112-24. Methods Enzymol. 1981. PMID: 6210825 Review. No abstract available.
Cited by
- Interplay between group A Streptococcus and host innate immune responses.
Su MS-W, Cheng Y-L, Lin Y-S, Wu J-J. Su MS-W, et al. Microbiol Mol Biol Rev. 2024 Mar 27;88(1):e0005222. doi: 10.1128/mmbr.00052-22. Epub 2024 Mar 7. Microbiol Mol Biol Rev. 2024. PMID: 38451081 Review. - The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance.
Xie HG, Jiang LP, Tai T, Ji JZ, Mi QY. Xie HG, et al. Mol Diagn Ther. 2024 Mar;28(2):189-199. doi: 10.1007/s40291-023-00691-w. Epub 2024 Jan 23. Mol Diagn Ther. 2024. PMID: 38261250 Review. - Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.
Murugaiah V, Varghese PM, Beirag N, De Cordova S, Sim RB, Kishore U. Murugaiah V, et al. Viruses. 2021 May 2;13(5):824. doi: 10.3390/v13050824. Viruses. 2021. PMID: 34063241 Free PMC article. Review. - C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus.
Varghese PM, Murugaiah V, Beirag N, Temperton N, Khan HA, Alrokayan SH, Al-Ahdal MN, Nal B, Al-Mohanna FA, Sim RB, Kishore U. Varghese PM, et al. Front Immunol. 2021 Jan 8;11:585361. doi: 10.3389/fimmu.2020.585361. eCollection 2020. Front Immunol. 2021. PMID: 33488586 Free PMC article. - The interaction between the complement system and hemostatic factors.
Oncul S, Afshar-Kharghan V. Oncul S, et al. Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605. Curr Opin Hematol. 2020. PMID: 32701617 Free PMC article. Review.
References
- J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
- J Exp Med. 1978 Jun 1;147(6):1792-1805 - PubMed
- Proc Natl Acad Sci U S A. 1978 Aug;75(8):3948-52 - PubMed
- J Exp Med. 1976 Nov 2;144(5):1147-63 - PubMed
- Immunochemistry. 1977 Nov-Dec;14(11-12):749-56 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous